The challenges involved in modeling toxicity data in silico: a review

Area of Science:

• Computational toxicology
• Pharmaceutical development
• Drug discovery

Background:

• Late-stage pharmaceutical development failures due to toxicity have increased.
• There is a growing need for rapid and reliable toxicity prediction methods.
• In silico models offer a promising approach to address these challenges.

Purpose of the Study:

• To review the challenges in building and applying in silico toxicology models.
• To assess the predictive strength of various in silico models for different toxicity endpoints.
• To discuss the limitations of current methods and data in model generation.

Main Methods:

• Review of existing literature on in silico toxicology models.
• Analysis of different approaches for model generation and rule creation.
• Evaluation of model complexity, interpretability, and predictability in the context of regulatory guidelines (e.g., OECD/REACH).

Main Results:

• The predictive strength of in silico models varies significantly depending on the toxicity endpoint.
• Balancing model complexity with interpretability and predictability is crucial.
• Data quality and methodology significantly impact the reliability of in silico toxicology models.

Conclusions:

• In silico toxicology is a valuable tool for drug discovery, but further advancements are required.
• A deeper understanding of biological toxicity mechanisms is essential.
• Development of more rapid in vitro screening models and increased data availability will enhance future in silico model performance.